ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease

O. Rascol, O. Blin, C. Thalamas, S. Descombes, C. Soubrouillard, P. Azulay, N. Fabre, F. Viallet, K. Lafnitzegger, S. Wright, J. H. Carter, J. G. Nutt

Research output: Contribution to journalArticlepeer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences